Search results
Results From The WOW.Com Content Network
This page was last edited on 1 November 2022, at 14:27 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Siam Bioscience Company, Ltd. (Thai: สยามไบโอไซเอนซ์) is a Thai drug manufacturer, [1] owned by King Maha Vajiralongkorn. [2]In 2009, the project started with a partnership between CPB Equity, subsidiary of Crown Property Bureau in the reign of King Bhumibol Adulyadej, and a medical human resource and pharmaceutical technology supporter's Mahidol University. [3]
Pages in category "Pharmaceutical companies of Thailand" The following 4 pages are in this category, out of 4 total. ... This page was last edited on 10 October 2019 ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Thailand exports over US$105 billion worth of goods and services annually. [3] Substantial industries include electric appliances, components, computer components, and vehicles. Thailand's recovery from the 1997–1998 Asian financial crisis depended mainly on exports, among various other factors.
The other games that made the top five include Mafia Wars, and Pet Society.Even though these games have the most users, it's also important to mention that Zynga's Roller Coaster Kingdom gained 14 ...
Although pharmaceutical companies have made large investments in marketing their products, overall promotional spending has been decreasing over the last few years, and declined by 10 percent from 2009 to 2010. Pharmaceutical companies are cutting back mostly in detailing and sampling, while spending in mailings and print advertising grew since ...